Auto Summaries

Last updated: 2025 Jul 18

Total hit(s): 5425

S.No.
1	40638574	Reframing SARS-CoV-2 evolution in India through an analysis of mutation prevalence across host demographics.	N/A	PLoS Negl Trop Dis	2025 Jul	4.4	1
2	40405267	Retraction Note: Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing.	N/A	Gut Pathog	2025 May 22		1
3	40171102	Whole-genome sequencing of SARS-CoV-2 from residual viral RNA present on positive rapid antigen test kits for genomic surveillance.	N/A	Western Pac Surveill Response J	2025 Jan-Mar		1
4	39840983	SARS-CoV-2 BA.2.86 is susceptible to the neutralizing antibody MO11 targeting subdomain 1 despite the E554K mutation near the epitope.	N/A	J Virol	2025 Jan 22	4.16	1
5	39833648	Correction: Identification of Novel Genomic Variants in COVID-19 Patients Using Whole-Exome Sequencing: Exploring the Plausible Targets of Functional Genomics.	N/A	Biochem Genet	2025 Jan 20		1
6	39586310	Enhanced immune evasion of SARS-CoV-2 variants KP.3.1.1 and XEC through N-terminal domain mutations.	N/A	Lancet Infect Dis	2024 Nov 22	21.77	1
7	39447388	Corrigendum to "Middle East respiratory syndrome coronavirus-a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins" [International Journal of Infectious Diseases (2023), volume 131, 87-94].	N/A	Int J Infect Dis	2024 Oct 23	3.42	1
8	39321502	Corrigendum to "The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study" [eBioMedicine, 2024;107:105273].	N/A	EBioMedicine	2024 Oct	6.49	1
9	39083043	Features of the SARS-CoV-2 KP.3 variant mutations.	N/A	Infect Dis (Lond)	2024 Jul 31	1.23	1
10	38961696	Is there an increased number of community-acquired pneumonia requiring drainage placement in children after COVID-19 pandemic in Italy?	N/A	Pediatr Pulmonol	2024 Jul 3	2.64	1
11	39030295	Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic.	N/A	Cell Res	2024 Jul 19	10.9	1
12	38809158	Another variant another history: description of the SARS-CoV-2 KP.2 (JN.1.11.1.2) mutations.	N/A	Infect Dis (Lond)	2024 Jul	1.23	1
13	38664266	Correction: Detection of SARS-CoV-2 spike protein D614G mutation using muTGGE.	N/A	Mol Biol Rep	2024 Apr 25	2.19	1
14	38272241		N/A		2024 Apr		1
15	38048665	Fixation and reversion of mutations in the receptor-binding domain of SARS-CoV-2 spike protein.	N/A	Diagn Microbiol Infect Dis	2024 Feb	2.33	1
16	38219759	Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution.	N/A	Lancet Microbe	2024 Jan 11	- n/a -	1
17	38224200	The roles of innate and adaptive immunity in inactivated viral vaccination-mediated protection against COVID-19.	N/A	Clin Transl Med	2024 Jan	4.08	1
18	38164631	The mutation point of view of the SARS-CoV-2 HV.1 lineage.	N/A	J Med Virol	2024 Jan	2.07	1
19	38149407	No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir.	N/A	J Med Virol	2024 Jan	2.07	1
20	39630770	Changes in the pathophysiology of viral variants of COVID-19 with a significant reduction in thrombotic events.	N/A	Rev Assoc Med Bras (1992)	2024	0.69	1
21	38129796	Correction: Near complete genome sequences from Southern Vietnam revealed local features of genetic diversity and intergenerational changes in SARS- CoV-2 variants in 2020-2021.	N/A	BMC Infect Dis	2023 Dec 21	2.58	1
22	36715434	Adverse events following the first, second and third doses of a COVID-19 vaccine in hemodialysis patients.	Study aimed to identify adverse events following the first three doses of COVID-19 vaccines in hemodialysis patients. Overall, 79%, 50% and 84% of the participants experienced at least one adverse event after their first, second, and third doses. Age, sex, dialysis vascular access and vaccine types were associated with postvaccination adverse events.	Ren Fail	2023 Dec	1.68	1
23	37144395	Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation.	The main protease (3-chymotrypsin-like protease, 3CLpro) of SARS-CoV-2 has become a focus of anti-coronavirus research. Despite efforts, drug development targeting 3CLPro has been hampered by limitations in the currently available activity assays. Here, we report an orthogonal dual reporter-based gain-of-signal assay for measuring 3Clpro activity in living cells. This assay circumvents most limitations in previously reported assays, especially false positives caused by nonspecific compounds and signal interference from test compounds.	Emerg Microbes Infect	2023 Dec	5.84	1
24	36788502	Novel COVID-19 vaccine hesitancy and acceptance, and associated factors, amongst medical students: a scoping review.	Medical students are likely to be exposed to COVID-19 patients so achieving high vaccination coverage rates for this group of healthcare workers is important. The aim of this scoping review was to evaluate the current literature to determine the rates of vaccine hesitancy and acceptance, and associated factors, amongst medical students.	Med Educ Online	2023 Dec	3.7	1
25	36594480	COVID-19 vaccine hesitancy between family decision-makers and non-decision-makers among college teachers.	A cross-sectional online survey was administered across mainland China from 4 to 7 August 2021. Overall, 42.2% of the teachers were hesitant to being vaccinated against COVID-19. The hesitancy rate was lower among primary decision-makers than that among non-decision-makers. Those engaged in nursing education versus non-medical related professional education (OR = 2.67, 95% CI 1.29-5.49) were more likely to be hesitant.	Ann Med	2023 Dec	3.01	1